Pier Capital’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-65,526	Closed	-$5.47M	–	131
2024 Q4	$5.47M	Sell	65,526 -34	-0.1%	-$2.79K	0.78%	77
2024 Q3	$4.8M	Buy	65,560 +1,056	+2%	+$79.4K	0.68%	83
2024 Q2	$4.42M	Buy	64,504 +10,050	+18%	+$697K	0.66%	79
2024 Q1	$3.77M	Sell	54,454 -596	-1%	-$41K	0.52%	87
2023 Q4	$3.94M	Sell	55,050 -94,079	-63%	-$5.41M	0.56%	83
2023 Q3	$7.77M	Sell	149,129 -1,664	-1%	-$96.9K	1.25%	25
2023 Q2	$9.55M	Buy	150,793 +2,897	+2%	+$181K	1.37%	20
2023 Q1	$8.01M	Buy	147,896 +5,155	+4%	+$249K	1.21%	27
2022 Q4	$7.55M	Sell	142,741 -1,297	-0.9%	-$65K	1.24%	36
2022 Q3	$6.7M	Buy	144,038 +27,392	+23%	+$1.43M	1.15%	43
2022 Q2	$6.66M	Buy	+116,646	New	+$6.61M	1.14%	45
2021 Q1	–	Sell	-190,833	Closed	-$6.07M	–	129
2020 Q4	$6.07M	Buy	+190,833	New	+$5.02M	0.64%	85
2015 Q3	–	Sell	-257,256	Closed	-$8.22M	–	132
2015 Q2	$8.22M	Buy	+257,256	New	+$6.52M	1.18%	11